Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.38 |
| ▸ | ESR1 | P03372 | 2/20 | 0.38 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.38 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TST | Q16762 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8054011 | 0.82 | PTGS2 (0.39) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL1685611 | 0.80 | KMT2A (0.41) | ALDH1A1LMNAKCNH2MEN1KMT2A | |
| SCHEMBL15306046 | 0.74 | KCNH2 (0.32) | LMNAHSD17B10KCNH2MEN1KMT2A | |
| SCHEMBL15306040 | 0.74 | KCNH2 (0.32) | LMNAHSD17B10KCNH2MEN1KMT2A | |
| SCHEMBL12539248 | 0.73 | KCNH2 (0.39) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL10815973 | 0.73 | MEN1 (0.37) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL27769289 | 0.71 | ALOX5 (0.41) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL29168795 | 0.70 | PTGS2 (0.40) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL8039222 | 0.70 | PTGS2 (0.40) | PTGS2ESR1ADRA2AADORA3TACR2 | |
| SCHEMBL1685616 | 0.69 | KCNH2 (0.53) | PTGS2ESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697256-B2 | Composition comprising phosphorescent compound and light emitting device using the composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-04-15 | — | — | US | disclosed |
| EP-2116574-B1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | SUMITOMO CHEMICAL CO (JP) | 2013-07-10 | — | — | EP | disclosed |
| CN-101616986-B | Composition containing pyrimidine compound and luminescent element employing the composition | SUMITOMO CO LTD | 2012-11-28 | — | — | CN | disclosed |
| CN-102105530-A | Composition comprising phosphorescence emitting compound, and light emitting element using the composition | SUMITOMO CHEMICAL CO | 2011-06-22 | — | — | CN | disclosed |
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| EP-2308926-A1 | COMPOSITION COMPRISING PHOSPHORESCENCE EMITTING COMPOUND, AND LIGHT EMITTING ELEMENT USING THE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-20100019203-A1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-28 | — | — | US | disclosed |
| CN-101616986-A | Contain the composition of pyrimidine compound and the luminous element that uses said composition to obtain | SUMITOMO CHEMICAL CO | 2009-12-30 | — | — | CN | disclosed |
| EP-2116574-A1 | COMPOSITION CONTAINING PYRIMIDINE COMPOUND AND LUMINESCENT ELEMENT EMPLOYING THE COMPOSITION | Sumitomo Chemical Company, Limited (JP) | 2009-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127467-A1 | COMPOSITION COMPRISING PHOSPHORESCENT COMPOUND AND LIGHT EMITTING DEVICE USING THE COMPOSITION | CCNE2, CDCA2, CCNA2 | PTGS2 3474/4885ESR1 317/4885ADRA2A 3648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.